Biological products hold enormous promise for the future of agriculture, but early validation remains one of the biggest hurdles for young AgBiotech companies. This session explores how startups can shorten development cycles through smart field-testing strategies, efficient regulatory navigation and early collaboration with receptive growers and scientific partners.

Investors share what evidence builds their conviction, from robust field data and clear regulatory pathways to early market pull, and discuss how streamlined validation environments can significantly reduce risk and accelerate scale. A practical and forward-looking conversation for founders and investors ready to bring the next generation of biologicals to market faster and with stronger backing.

May 20 @ 15:15
15:15 — 16:10 (55′)

Stage 2 – Auditorium

Francisco Jardim | SP Ventures

PLEASE KEEP ME INFORMED BY EMAIL ABOUT EVENT UPDATES!